CNS-targeted Viral Delivery of G-CSF in an Animal Model for ALS: Improved Efficacy and Preservation of the Neuromuscular Unit
Authors:
Open Access
- 1 February 2011
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 19 (2) , 284-292
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Transient Demyelination Increases the Efficiency of Retrograde AAV TransductionMolecular Therapy, 2010
- G-CSF protects motoneurons against axotomy-induced apoptotic death in neonatal miceBMC Neuroscience, 2010
- Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand ?Frontiers in Neuroscience, 2010
- Self-complementary AAV Virus (scAAV) Safe and Long-term Gene Transfer in the Trabecular Meshwork of Living Rats and MonkeysInvestigative Ophthalmology & Visual Science, 2010
- Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor NeuronsMolecular Therapy, 2009
- Viral vectors: from virology to transgene expressionBritish Journal of Pharmacology, 2009
- Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosisBrain, 2008
- Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell ActivityMolecular Therapy, 2008
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALSBrain Research, 2007